Redmile Group LLC 13D and 13G filings for ImmunoGen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | ImmunoGen, Inc. IMGN |
Redmile Group LLC | 16,423,922 5.900% |
-3,472,531 (-17.45%) |
Filing |
| 2023-02-14 4:20 pm Purchase |
2022-12-31 | 13G | ImmunoGen, Inc. IMGN |
Redmile Group LLC | 19,896,453 8.600% |
274,472 (+1.40%) |
Filing |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | ImmunoGen, Inc. IMGN |
Redmile Group LLC | 19,621,981 8.500% |
9,093,802 (+86.38%) |
Filing |
| 2021-02-16 4:10 pm Sale |
2020-12-31 | 13G | ImmunoGen, Inc. IMGN |
Redmile Group LLC | 10,528,179 5.600% |
-4,111,781 (-28.09%) |
Filing |